Psoriatic Arthritis
Conference Coverage
Debate Over Axial Involvement in Psoriatic Arthritis Still Unresolved Despite New Studies
Data from two studies corroborated what was already known about axial psoriatic arthritis rather than help define or differentiate it further from...
News from the FDA/CDC
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
The biosimilar is approved for all indications of the reference medication, Stelara, and will launch in February 2025.
Conference Coverage
Psoriatic Arthritis Symptoms Relieved with TYK2 Inhibitor in Phase 2 Trial
More than half of patients assigned to TAK-279 achieved ACR20 at 12 weeks, compared with 30% of patients assigned to placebo in a phase 2 clinical...
Conference Coverage
Psoriatic Arthritis Drug Candidate Sonelokimab Yields Significant Improvements in Phase 2 Trial
Patients receiving sonelokimab experienced higher treatment response in ACR20, ACR50, and PASI90 than those in the placebo group.
Conference Coverage
Latest Izokibep Trial for PsA Shows Promise But Misses on Enthesitis
The primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce enthesitis more than placebo, as might have been...
Conference Coverage
What’s in a Name: Defining Difficult-to-Treat axSpA and PsA
Ongoing efforts aim to differentiate biologically refractory cases from cases with comorbid conditions and social factors that can contribute to...
Conference Coverage
EULAR 2024 Preview: Therapeutics in Development Take Center Stage
Experts give their top picks and hot tips on data being presented at the upcoming European Congress of Rheumatology taking place on June 12-15 in...
From the Journals
Clear Coverage Preference for Humira Over Biosimilars Seen in Most Medicare Part D Plans
This narrow coverage limits the cost-saving potential of these biosimilar competitors, the authors of a new study said.
Latest News
Over-the-Counter Arthritis Supplements Pose Adrenal Danger
Patients taking OTC arthritis supplements may need to taper use to avoid adrenal insufficiency, dysfunction, says presenter.
Latest News
Study Finds Mace Risk Remains High in Patients with Psoriasis, Dyslipidemia
Current guidelines recommend statins “for patients with psoriasis who have additional risk-enhancing factors, similar to recommendations made for...
From the Journals
Cortisol Test Confirms HPA Axis Recovery from Steroid Use
A test that measures serum cortisol levels to predict recovery of the hypothalamic-pituitary-adrenal axis in patients tapering down chronic...